期刊文献+

HPLC法测定加巴喷丁胶囊的含量及有关物质 被引量:2

Determination of Gabapentin and Related Substances in Gabapentin Capsules by HPLC
下载PDF
导出
摘要 目的:用高效液相色谱法测定加巴喷丁胶囊的含量及有关物质。方法:采用Kromasil C8柱(250 mm×4.6 mm,5μm);流动相:甲醇-0.01 mol·L-1磷酸二氢钾溶液(用2 mol·L-1氢氧化钾溶液调p H 6.9)(40∶60);检测波长:210 nm;柱温:40℃;进样量:20μl。采用外标法测定主成分和已知杂质的含量,自身对照法测定未知杂质的含量。结果:加巴喷丁浓度在2.5~20.0 mg·ml-1范围内与峰面积呈良好的线性关系(r=0.999 9)。平均加样回收率为100.74%(RSD=0.24%,n=5)。结论:本方法快速、准确、专属性好,可用于加巴喷丁胶囊的含量及有关物质测定。 Objective:To establish an HPLC method for the determination of gabapentin and the related substances in gabapentin capsules. Methods:A Kromasil C8 column (250 mm × 4. 6 mm,5μm)was used. The mobile phase was methanol-0. 01 mol·L-1 po-tassium dihydrogen phosphate solution (adjusting pH to 6. 9 with 2 mol·L-1 potassium hydroxide) (40∶60). The detection wave-length was 210 nm. The column temperature was 40℃ and the injection volume was 20μl. The main component and the known impuri-ty were determined by an external standard method. The unknown impurities were determined by a self-control method. Results: The calibration curve of gabapentin was linear within the range of 2.5-20.0 mg·ml-1(r=0.999 9). The average sample recovery was 100. 74% with RSD of 0. 24%(n=5). Conclusion:The method is simple, accurate,specific and applicable in the determination of gabapentin and the related substances in gabapentin capsules.
出处 《中国药师》 CAS 2015年第3期520-522,共3页 China Pharmacist
关键词 加巴喷丁 高效液相色谱法 含量 有关物质 Gabapentin HPLC Content Related substances
  • 相关文献

参考文献2

二级参考文献21

  • 1朱国行,丁美萍,肖波,王德新,王德生,潘以正,赵庆臣,潘映福,马广玉,洪震,吕传真.加巴喷丁对难治性癫痫的治疗作用[J].中华医学杂志,2005,85(2):92-95. 被引量:21
  • 2汪震,刘东,龚培力,杨晓燕,曾繁典,袁祯.高效液相色谱荧光检测法测定血浆加巴喷丁含量[J].中国药师,2005,8(8):676-678. 被引量:6
  • 3金毅,李炜,徐建国,李伟彦,刘健.国产加巴喷丁治疗带状疱疹后神经痛的临床疗效及安全性[J].医学研究生学报,2006,19(11):998-1000. 被引量:23
  • 4TAYLOR CP,VARTANIAN MG,YUEN P,et al.Potent and stereospecific anticonvulsant of 3-isobutyl GABA relates to in vitro binding at a novel site labelled by tritiated gapapentin[J].Epitepsy Res,1993,14(1):11-15.
  • 5TAYLOR CP.Emerging perspectives on the mechanism of action of gabapentin[J].Neurology,1994,44(Suppl 5):S10-S16.
  • 6HARDEN CL.New antiepileptic drugs[J].Neurology,1994,44(Suppl 5):S787-S789.
  • 7LOUIS L,CHARLES P,ROBIN M.Preclinical pharmacology,pharmacokinetics and toxicology of gabapentin[J].Drugs Today,1995,31(8):597-611.
  • 8MELEAN MJ.Clinical pharmacokineties of gabapentin[J].Neurology,1994,44(Suppl 5):S17-S19.
  • 9VOLLMER KO,KOLIE EU.Pharmacokinetics and metabolism of gabapentin in rat,dog and man[J].Arzneim-Forsch,1986,36(I):830-839.
  • 10ELDON MA,UNDERWOOD BA,RANDINITIS EJ,et al.Lack of effect of gabapentin on the pharmacokinetics of norethindron acetate/ethinyl estradiolcontaining oral contraceptive[J].Neurology,1993,43(Suppl 2):S3-S7.

共引文献22

同被引文献14

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部